Search Indian Maps, Pincodes, Local Info and more...
Indian Pharmacopoeia Commission
An autonomous body, Indian Pharmacopoeia Commission (IPC) was established by the government of India to work under the guidelines of the Ministry of Health and Family Welfare. Important roles of this Commission are to set as well as maintain the proper standard for supply and use of different types of drugs manufactured.
About Indian Pharmacopoeia Commission
Indian Pharmacopoeia Commission (IPC) was established with keeping important aspects into consideration to sell of various drugs and their consumption in country is made transparent to the best extent. IPC keeps the standards into consideration while doing its duties for the following purposes:-
- Standards published under the Indian Pharmacopoeia (IP) title to maintain all records
- Entire Indian subcontinent gest guidance to use drugs in any form through maintaining awareness
- It is made compulsory for the drugs manufactured in India to be labeled with non-proprietary drug name using suffix I.P compulsory as per instructions set by the IPC
First Indian Pharmacopoeia Commission
It was in 1940 that Indian Drugs and Cosmetics Act, 1940 was passed to smoothen establishment of first IPC. Government of India took keen interest through taking an initiative to issue orders for the formation of this Commission before 1945. Once formed, IPC took several important initiatives out of which starting a process to publish the first Pharmacopoeia was important achievement which began in 1944 itself. This important step was completed with Col. R. N. Chopra being appointed Commission chairman to look into such an important tasks.
Mandate & Publications
Publication of first I.P. list completed two years later in 1946. By then its mandate was already planned. Reports were sent to authorities for approval purpose with the unique title setups having suffixes of years concerned to ensure maintaining yearly records. Some of the important facts related to IPC publications are as follows:-
- Official Gazette published 1st edition I.P.1955 under the chairmanship of Dr. B.N. Ghosh
- Dr. B. Mukherji was chairman of the 2nd edition I.P1966 publication
- A supplement publication arrived in 1960
- Another supplement arrived in 1975
- With Dr. Nityanand as chairman, 3rd edition, I.P. 1985 was also published
- Supplement publications arrived in years 1990 and 1991
Recommendation Reports & Publications
IPC remained active in the recent years and kept publishing reports to regulate the drugs industry on regular basis. Publication of 4th edition I.P.1996 under the chairmanship of Dr. Nityanand and publishing supplements in 2000 & 2002 and came with 5th edition of I.P.2007 under his chairmanship. The 6th edition of IPC publication arrived recently in 2010 as I.P.2010 issue.
Ever since IPC has been formed and made to work independently as a Commission without bound to any pressures etc. the Ministry of Health and Family Welfare of the Government of India has witnessed tremendous reforms in healthcare sector. Some notable achievements are proper creation of standards in drug industry which resultantly brought important developments in terms of industry operation from the basic to advanced stages.
Many attempts have been made to update standards on regular basis. The drug manufacturers who supply and sell in the country are now aware that special teams keep monitoring them so they mustn’t deviate from actual motive while supplying drugs for the treatment purpose.
Implementation of Recommendations
Regular publication of all the official documents to improve the quality of medicines manufactured in India and to add new value besides ensuring a thorough update on the existing drugs are some major implementations. This Commission also plays an active role to promote suitable and unbiased use of medicines supplied into market.
IPC published National Formulary of India for the effective guidance on drugs and medicines, so are other benefits it has been offering. Checklist of additional roles are mentioned below:-
- Use of IP to standardize and maintain identity besides purity level in drugs manufacturing
- Ensuring through regulations that drugs supply and manufacturing is suitable for healthcare of humans or animals for that steps are taken
- Use of IP Reference Substances (IPRS) proves effective tool for all sorts of identification purposes to maintain purity level and drug testing
Ever since IPC was formed and IP standards supported there has occurred total authoritative development in this sector. Regulatory authorities are involved for such enforcement especially to keep control over medicines manufactured, supplied or sold in the Indian subcontinent. IP standards have been given special status of legally acceptable in case where occurs any sort of dispute to measure for quality assurance and disputes go to court of law for resolution. It indicates the importance of total quality assurance.
IPC takes into account IP which is an important official document to crosscheck and monitor total quality control and timely assurance for the effective control of drugs and all pharmaceutical items which are commonly produced in Indian subcontinent. Main purpose is that drugs remain under control for the safety standards through keeping in view their affordability and efficiency in all respects.
This Commission collaborates with several parties especially scientific bodies like Central Drugs Standard Control Organization (CDSCO) or State Regulatory authorities and experts from industry or various associations to councils et al for the proper guidance and effective performance of healthcare sector as a whole.